NCT05607225 Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients Status UNKNOWN Phase N/A
NCT05595590 Radiotherapy With Tislelizumab in Patients With Recurrent Head & Neck Cancer Status RECRUITING Phase PHASE2
NCT05594069 Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients Status COMPLETED Phase NA
NCT05588973 Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus Status UNKNOWN Phase NA
NCT05582590 Autologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers Status NOT_YET_RECRUITING Phase PHASE1
NCT05576974 A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) Status RECRUITING Phase PHASE2
NCT05557825 The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients Status COMPLETED Phase N/A
NCT05553782 Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers Status RECRUITING Phase EARLY_PHASE1
NCT05544136 A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer Status RECRUITING Phase PHASE2
NCT05542706 Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer Status RECRUITING Phase NA
NCT05540899 Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05539144 A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer Status COMPLETED Phase NA
NCT05538533 Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05535023 Phase 2 Study of Neoadjuvant SAR444245 Plus Cemiplimab in HPV Related Oropharynx Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE2
NCT05526924 Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer Status RECRUITING Phase PHASE1
NCT05526040 Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment Study Status UNKNOWN Phase NA
NCT05524454 Evaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy Status COMPLETED Phase NA
NCT05517330 Neoadjuvant Tislelizumab With Afatinib for Resectable Head and Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE2